SARS-CoV-2 Nucleocapsid Products
(SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N))
Categories
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured SARS-CoV-2 Nucleocapsid Categories
SARS-CoV-2 Nucleocapsid Antibodies
High quality antibodies with extensive validation data.
SARS-CoV-2 Nucleocapsid Proteins
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended SARS-CoV-2 Nucleocapsid Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
SARS Coronavirus-2 (SARS-CoV-2), Virus
Application
ELISA, WB
Validations
- (6)
- (3)
Cat. No.
ABIN6952435
Quantity
100 μL
Datasheet
Datasheet
Reactivity
SARS Coronavirus-2 (SARS-CoV-2)
Application
ELISA, WB, GICA
Validations
- (1)
- (2)
Cat. No.
ABIN6952664
Quantity
100 μL
Datasheet
Datasheet
Reactivity
SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
Application
ELISA, IF
Validations
- (3)
- (2)
Cat. No.
ABIN6953059
Quantity
200 μg
Datasheet
Datasheet
Recommended SARS-CoV-2 Nucleocapsid ELISA Kits
Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human, SARS Coronavirus-2 (SARS-CoV-2)
Analytical Method
Quantitative Sandwich ELISA
Validations
Cat. No.
ABIN6952756
Quantity
96 tests
Datasheet
Datasheet
Recommended SARS-CoV-2 Nucleocapsid Proteins
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
SARS Coronavirus-2 (SARS-CoV-2)
Source
HEK-293 Cells
Validations
- (5)
- (2)
Cat. No.
ABIN6952454
Quantity
100 μg
Datasheet
Datasheet
Reactivity
SARS Coronavirus-2 (SARS-CoV-2)
Source
Escherichia coli (E. coli)
Validations
- (1)
- (2)
Cat. No.
ABIN6952658
Quantity
200 μg
Datasheet
Datasheet
Reactivity
SARS Coronavirus-2 (SARS-CoV-2)
Source
Escherichia coli (E. coli)
Validations
- (1)
Cat. No.
ABIN7274433
Quantity
100 μg
Datasheet
Datasheet
Latest Publications for our SARS-CoV-2 Nucleocapsid products
: "Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection." in: PloS one, Vol. 18, Issue 2, pp. e0281281, (2023) (PubMed).: "Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®. ..." in: Vaccines, Vol. 11, Issue 4, (2023) (PubMed).
: "Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2. ..." in: Nature communications, Vol. 14, Issue 1, pp. 3583, (2023) (PubMed).
: "Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Issue 30, pp. e2221809120, (2023) (PubMed).
: "Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern." in: Journal of dairy science, (2022) (PubMed).
: "Identification of cell type specific ACE2 modifiers by CRISPR screening." in: PLoS pathogens, Vol. 18, Issue 3, pp. e1010377, (2022) (PubMed).
: "The Potential of Eukaryotic Cell-Free Systems as a Rapid Response to Novel Zoonotic Pathogens: Analysis of SARS-CoV-2 Viral Proteins." in: Frontiers in bioengineering and biotechnology, Vol. 10, pp. 896751, (2022) (PubMed).
: "Paper-Based Test for Rapid On-Site Screening of SARS-CoV-2 in Clinical Samples." in: Biosensors, Vol. 11, Issue 12, (2022) (PubMed).
: "ARF6 is an important host factor for SARS-CoV-2 infection in vitro." in: bioRxiv : the preprint server for biology, (2022) (PubMed).
: "Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial." in: Virus research, Vol. 316, pp. 198791, (2022) (PubMed).
Synonyms and alternative names related to SARS-CoV-2 Nucleocapsid
nucleocapsid phosphoprotein (N)Did you look for something else?
- SARS-CoV-2 NSP9
- SARS-CoV-2 NSP8
- SARS-CoV-2 NSP7
- SARS-CoV-2 NSP6
- SARS-CoV-2 NSP5 (3CL-Pro)
- SARS-CoV-2 NSP4
- SARS-CoV-2 NSP3
- SARS-CoV-2 NSP2
- SARS-CoV-2 NSP16
- SARS-CoV-2 NSP15
- SARS-CoV-2 NSP14
- SARS-CoV-2 NSP13
- SARS-CoV-2 NSP12 (RdRP)
- SARS-CoV-2 NSP10
- SARS-CoV-2 NSP1
- SARS-CoV-2 Membrane Protein
- SARS-CoV-2 Envelope
- SARS-CoV-2 (CB6 Biosimilar)
- SARS-CoV-2
- SARS-CoV Spike
You are here:
